Join
Live feed
·
INSIDERFilingvia Quantisnow
Akebia Therapeutics Inc. logo

SVP, Chief Medical Officer Burke Steven Keith was granted 194,900 shares and sold $106,063 worth of shares (50,506 units at $2.10), increasing direct ownership by 21% to 816,234 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKBA (Akebia Therapeutics Inc.) and more on Quantisnow.